MPM Capital

Investor type

PE / VC

Founded

1996

AUM

-

Location

United States

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 12 February, 2026

Profile

MPM Capital is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM strives to power novel medical breakthroughs that transform patients’ lives. MPM invests across the biotech landscape with early-stage venture capital funds, and with impact and public equities products through its affiliate BioImpact Capital.

Industry

Life Sciences Healthcare Services Technology MedTech AI Software Medical Devices Biotechnology HealthTech

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
FryNLalH5oXAbQ14 FryNLalH5oXAbQ14
FryNLalH5oXAbQ14
avatar
FryNLalH5oXAbQ14 FryNLalH5oXAbQ14
FryNLalH5oXAbQ14
avatar
FryNLalH5oXAbQ14 FryNLalH5oXAbQ14
FryNLalH5oXAbQ14
avatar
FryNLalH5oXAbQ14 FryNLalH5oXAbQ14
FryNLalH5oXAbQ14
avatar
FryNLalH5oXAbQ14 FryNLalH5oXAbQ14
FryNLalH5oXAbQ14
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about MPM Capital

MPM Capital is located in United States.
MPM Capital was founded in 1996.
MPM Capital invests in companies and startups in Life Sciences, Healthcare Services, Technology, MedTech, AI, Software, Medical Devices, Biotechnology, HealthTech.
MPM Capital invests in companies and startups in North America, Europe.
MPM Capital invests in companies and startups at Seed, Series B, Series A.
MPM Capital usually invests $0-1 m on average.